About
Laminate Medical Technologies Ltd. is a biotechnology company founded in 2012, dedicated to enhancing the success and functionality of arteriovenous fistulas (AVFs) for hemodialysis patients. The company addresses the challenges of high failure rates in primary fistulas, which can reach up to 60%. Their flagship product, the VasQ™ External Support, is designed to improve fistula maturation and decrease the need for repeat procedures. Clinical studies have shown that VasQ significantly increases the likelihood of fistulas becoming functional without additional interventions, leading to better patient outcomes. The product has received regulatory recognition, including a Transitional Pass-Through payment status, which supports its adoption in clinical settings. Headquartered in New York City, Laminate Medical Technologies has a global team of experts from Israel, Europe, and the United States. The company has raised approximately $16 million in funding to further its development and commercialization efforts, aiming to expand the availability of VasQ and innovate in vascular access for dialysis patients worldwide.
Technologies
Keywords
Company Information
-
Employees 29
-
Founded 2012
-
Annual Revenue $2500000
-
Total Funding $20000000
Location
Tel Aviv-Yafo, Israel